Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)
Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)
Active, not recruiting · NCT05285826 · Registry updated 2024-12-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052) | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 3 | 2024-12-16 | NCT05285826 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
34 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.